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Method 1: The GMM Model.
To deconvolute the overlapped peaks of the distributions of the L1000 analyte fluorescent intensities, we assumed that the fluorophore intensities of each analyte type (corresponding to a specific mRNA type) subjected to a Gaussian distribution. The distribution of the mixture of analytes Gene H (i) and Gene L (i) corresponding to the expression levels of Gene H and Gene L , respectively, should subject to a two Gaussian mixture, with the proportion of 1.25 to 0.75: The objective function for GMM optimization was: Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is © The Royal Society of Chemistry 2015
Method 2: The EGEM score. Figure S1 . EGEM score construction. The up-and down-DEGs after a gene knockdown treatment are used as two feature sets.
The locations of up-and down feature sets in the ascendant-and descendant-sorted gene list after a compound treatment are measured by Kolmogorov-Smirnov statistic. The value is normalized by the total size of up-and down feature sets.
We defined the EGEM score to describe the similarity between the treatments of a compound and an shRNA targeting a gene using the mutual enrichment of their resultant differential expressed landmark genes. The EGEM metric was derived from the rank-based gene set enrichment analysis (GSEA) [1] and the connectivity analysis [2] . Compound treatments could be taken as "phenotypes" and the differentially expressed genes (DEGs) of a single gene knocking down treatment as a "signature gene set" in the GSEA terminology. The EGEM metric enabled gene set enrichment analysis against the LINCS target gene reference library.
The construction of EGEM score was shown in Figure S1 . 
The EGEM score ranges from -1 to 1. The absolute value of an EGEM score represents the enrichment degree. The positive or negative sign of an EGEM score indicates that the change of gene expression pattern due to knocking down the corresponding gene is similar or reversely similar to that induced by the drug treatment. The statistical significance of an EGEM score was determined by t-test against permutations of 100 times. The EGEM scores were kept only if the associated p-values were less than 0.05 and otherwise were set to zero.
We constructed an EGEM matrix by pairwisely calculating the EGEM score between each compound and each knockdown gene. We assumed that both the positive and negative EGEM scores followed normal distributions. We also assumed that the EGEM matrix was sparse by observing the fact that, among the 3,000 proteins, a compound usually only targets a limited number of them. 
where is a row vector with all components equal to one and is a zero vector, is an
and is a zero matrix of size
Then, the objective function can be written as:
According to Eq. S1, the problem of csNMF can be solved by the multiplicative update rules: Determine the optimal signatures. We constructed the adjacency matrix : 
0, others
Determine the optimal signature number. We used the cophenetic correlation coefficient (CCC) method [4] to measure the stability of the clustering results and thus to determine the optimal cluster number. Briefly, the cosine similarity [5] between each adjacency matrix and the average , , ( , )
. The cosine similarity was chosen over Pearson's correlation because it has been shown ̅ , insensitive to zeroes [6] which were abundant in adjacency matrixes.
Adjacency matrix construction and signature number determination
After performing csNMF approach, EGEM matrix is decomposed into weight and coefficient matrixes.
The next is to assigning the elements (compounds and genes) to different signatures. This fulfils by a adjacency matrix C, which is a 0-1 matrix of size k x n, if element j is clustered to signature i,
if not [7] . 
As to the adjacency matrixes C M (M is V, t(W 1 ), t(W 2 ) of the csNMF results, t(M)
0
while do while do
Disorder the genes and compounds of the EGEM matrix randomly.
Solve the csNMF problem based on Eq. S2 and Eq. S3.
Build the i th connectivity matrix C H , C t(Ws) , C t(wr)
.
end while
Determine the signature detection results based on k.
Calculate the consistence degrees based on k. end while 7. Determine the stable signatures of each based on Eq. S5 8. Determine the optimal and obtain the signature detection result.
9. The Biological analysis of each signature. 
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